4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-23-121648
Chief Financial Officer sold 10,974 shares at $35.02 ($384,336)
- Chief Financial Officer acquired 10,974 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Smith Hunter C Chief Financial Officer | 2023-11-24 | Option exercise | +10,974 | $6.88 | $75,501 | 72,380 | D |
| Smith Hunter C Chief Financial Officer | 2023-11-24 | Sale | −10,974 | $35.02 | $384,336 | 61,406 | D |
| Derivatives | |||||||
| Smith Hunter C Chief Financial Officer | 2023-11-24 | Option exercise · Stock Option (Right to Buy) | −10,974 | 138,120 | D | ||
| Open-market sales · 10,974 sh · avg $35.02 · $384,336 | |||||||
Loading xslF345X05/tm2331580-1_4seq1.xml…